M-CSFR (also known as CSF1-R) inhibitors induce the depletion of tumor infiltrating macrophages or their polarization towards a pro-inflammatory phenotype, with beneficial effects for mesothelioma regression (43, 44). Here, CSF1R is linked to neoplasm.